A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
- PMID: 30067922
- DOI: 10.1056/NEJMoa1803760
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Abstract
Background: The indirect water-deprivation test is the current reference standard for the diagnosis of diabetes insipidus. However, it is technically cumbersome to administer, and the results are often inaccurate. The current study compared the indirect water-deprivation test with direct detection of plasma copeptin, a precursor-derived surrogate of arginine vasopressin.
Methods: From 2013 to 2017, we recruited 156 patients with hypotonic polyuria at 11 medical centers to undergo both water-deprivation and hypertonic saline infusion tests. In the latter test, plasma copeptin was measured when the plasma sodium level had increased to at least 150 mmol per liter after infusion of hypertonic saline. The primary outcome was the overall diagnostic accuracy of each test as compared with the final reference diagnosis, which was determined on the basis of medical history, test results, and treatment response, with copeptin levels masked.
Results: A total of 144 patients underwent both tests. The final diagnosis was primary polydipsia in 82 patients (57%), central diabetes insipidus in 59 (41%), and nephrogenic diabetes insipidus in 3 (2%). Overall, among the 141 patients included in the analysis, the indirect water-deprivation test determined the correct diagnosis in 108 patients (diagnostic accuracy, 76.6%; 95% confidence interval [CI], 68.9 to 83.2), and the hypertonic saline infusion test (with a copeptin cutoff level of >4.9 pmol per liter) determined the correct diagnosis in 136 patients (96.5%; 95% CI, 92.1 to 98.6; P<0.001). The indirect water-deprivation test correctly distinguished primary polydipsia from partial central diabetes insipidus in 77 of 105 patients (73.3%; 95% CI, 63.9 to 81.2), and the hypertonic saline infusion test distinguished between the two conditions in 99 of 104 patients (95.2%; 95% CI, 89.4 to 98.1; adjusted P<0.001). One serious adverse event (desmopressin-induced hyponatremia that resulted in hospitalization) occurred during the water-deprivation test.
Conclusions: The direct measurement of hypertonic saline-stimulated plasma copeptin had greater diagnostic accuracy than the water-deprivation test in patients with hypotonic polyuria. (Funded by the Swiss National Foundation and others; ClinicalTrials.gov number, NCT01940614 .).
Comment in
-
A Reliable Diagnostic Test for Hypotonic Polyuria.N Engl J Med. 2018 Aug 2;379(5):483-484. doi: 10.1056/NEJMe1808195. N Engl J Med. 2018. PMID: 30067935 No abstract available.
-
Copeptin in the Diagnosis of Diabetes Insipidus.N Engl J Med. 2018 Nov 1;379(18):1784. doi: 10.1056/NEJMc1811694. N Engl J Med. 2018. PMID: 30382697 No abstract available.
-
Copeptin in the Diagnosis of Diabetes Insipidus.N Engl J Med. 2018 Nov 1;379(18):1784. doi: 10.1056/NEJMc1811694. N Engl J Med. 2018. PMID: 30382698 No abstract available.
-
Copeptin in the Diagnosis of Diabetes Insipidus.N Engl J Med. 2018 Nov 1;379(18):1784-5. doi: 10.1056/NEJMc1811694. N Engl J Med. 2018. PMID: 30382699 No abstract available.
Similar articles
-
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74. doi: 10.1210/jc.2014-4507. Epub 2015 Mar 13. J Clin Endocrinol Metab. 2015. PMID: 25768671
-
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests.J Clin Endocrinol Metab. 2011 May;96(5):1506-15. doi: 10.1210/jc.2010-2345. Epub 2011 Mar 2. J Clin Endocrinol Metab. 2011. PMID: 21367924
-
Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.N Engl J Med. 2023 Nov 16;389(20):1877-1887. doi: 10.1056/NEJMoa2306263. N Engl J Med. 2023. PMID: 37966286 Clinical Trial.
-
Copeptin in the differential diagnosis of hypotonic polyuria.J Endocrinol Invest. 2020 Jan;43(1):21-30. doi: 10.1007/s40618-019-01087-6. Epub 2019 Jul 31. J Endocrinol Invest. 2020. PMID: 31368050 Review.
-
Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia.Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):235-47. doi: 10.1016/j.beem.2016.02.003. Epub 2016 Feb 16. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27156761 Review.
Cited by
-
Arginine Vasopressin Deficiency Heralding Rosai-Dorfman Disease With Neurological Manifestations.JCEM Case Rep. 2024 Nov 7;2(12):luae206. doi: 10.1210/jcemcr/luae206. eCollection 2024 Dec. JCEM Case Rep. 2024. PMID: 39526030 Free PMC article.
-
Propofol-induced transient arginine vasopressin deficiency.Endocrinol Diabetes Metab Case Rep. 2024 Oct 28;2024(4):24-0083. doi: 10.1530/EDM-24-0083. Print 2024 Oct 1. Endocrinol Diabetes Metab Case Rep. 2024. PMID: 39475829 Free PMC article.
-
An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management.J Clin Med. 2024 Oct 16;13(20):6161. doi: 10.3390/jcm13206161. J Clin Med. 2024. PMID: 39458112 Free PMC article. Review.
-
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).Nat Rev Nephrol. 2024 Oct 22. doi: 10.1038/s41581-024-00897-z. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 39438674 Review.
-
Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2024 Oct 5;25(19):10743. doi: 10.3390/ijms251910743. Int J Mol Sci. 2024. PMID: 39409072 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical